Jenni Ilomakiمشاهده پروفایل
دانشیار
Associate Professor Jenni Ilomaki holds a position at Monash University's Centre for Medicine Use and Safety. With expertise in clinical pharmacy, epidemiology, and public health, she leads a research group analyzing administrative claims data. Her work spans collaborations with governmental and non-governmental organizations globally, yielding over 150 peer-reviewed publications and $4 million in grants. She previously served as Chair of ASCEPT's Pharmacoepidemiology Special Interest Group and currently serves as Science Lead for the Monash Addiction Research Centre and Executive Editor of the British Journal of Clinical Pharmacology. Education includes a Bachelor of Science (Pharmacy) from the University of Kuopio (1999) and Master of Science (Pharmacy) from the University of Kuopio (2004). She completed a PhD in alcohol epidemiology at the University of Eastern Finland (2011) and a postdoc at the University of South Australia (2011-2014). Notable recognitions include Young Epidemiologist of the Year (2011) and the Ronald D. Mann Best Paper Award (2021). Key research focuses on quality use of medicines, medicine safety, large population studies, and innovative epidemiological methods. Major projects include developing clinical decision support tools for cardiovascular prevention, analyzing preventable hospitalizations in aged care, and investigating psychotropic medication trends in youth. Her work contributes to UN Sustainable Development Goals related to health equity and non-communicable disease reduction. Recent publications emphasize drug repurposing (e.g., SGLT2 inhibitors), opioid prescribing patterns, hip fracture outcomes, and dementia detection algorithms. She chairs multinational studies on stroke and myocardial infarction cost burdens, demonstrating interdisciplinary impact across pharmacology, epidemiology, and health economics.






